From the outset of the COVID-19 outbreak, MPP realised that equitable access to treatments would be essential in the fight against this global threat. MPP issued a statement on 5
Read Full
A need for equity in access to COVID-19 vaccines – The mRNA vaccine Technology Transfer Hub was established in response of the flagrant inequities in access to COVID-19 vaccines in low- and
Read Full
Unfounded rumours have been circulating that the mRNA vaccine technology transfer hub being established in South Africa with the support of the Government of South Africa, the African CDC, the
Read Full
Petro Terblanche is the managing director of a Afrigen,a South African biotechnology company working with the WHO to produce an Covid-10 mRNA vaccine that is similar to the one produced
Read Full
The World Health Organization this week announced it will establish its first-ever mRNA technology transfer hub in the city in an agreement with Afrigen Biologics & Vaccines and the Biovac
Read Full
MPP, WHO, AFRIGEN, BIOVAC, SAMRC, and Africa CDC sign a letter of intent towards establishing the tech transfer hub in South Africa. Geneva – The Medicines Patent Pool (MPP) and the World
Read Full
